Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001683168-17-000544
Filing Date
2017-03-13
Accepted
2017-03-13 08:38:25
Documents
52
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT FOR XBRL pharmacyte_10qa-013117.htm 10-Q/A 19130
  Complete submission text file 0001683168-17-000544.txt   2261567

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE pmcb-20170131.xml EX-101.INS 509696
3 XBRL SCHEMA FILE pmcb-20170131.xsd EX-101.SCH 28295
4 XBRL CALCULATION FILE pmcb-20170131_cal.xml EX-101.CAL 39742
5 XBRL DEFINITION FILE pmcb-20170131_def.xml EX-101.DEF 118947
6 XBRL LABEL FILE pmcb-20170131_lab.xml EX-101.LAB 217854
7 XBRL PRESENTATION FILE pmcb-20170131_pre.xml EX-101.PRE 183371
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q/A | Act: 34 | File No.: 333-68008 | Film No.: 17684079
SIC: 2833 Medicinal Chemicals & Botanical Products